Published in Pharmacogenet Genomics on October 01, 2013
A novel UGT1 marker associated with better tolerance against irinotecan-induced severe neutropenia in metastatic colorectal cancer patients. Pharmacogenomics J (2015) 0.91
FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy. World J Gastroenterol (2014) 0.83
Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer. World J Gastroenterol (2015) 0.79
OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy. Br J Cancer (2015) 0.78
UGT1A1 polymorphisms in cancer: impact on irinotecan treatment. Pharmgenomics Pers Med (2017) 0.75
Two SNPs of ATP-binding cassette B1 gene on the risk and prognosis of colorectal cancer. Int J Clin Exp Pathol (2015) 0.75
Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228). Br J Cancer (2017) 0.75
Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma. J Cancer (2017) 0.75
Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst (2005) 6.69
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer. N Engl J Med (2014) 4.81
Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol (2002) 3.53
The role of UGT1A1*28 polymorphism in the pharmacodynamics and pharmacokinetics of irinotecan in patients with metastatic colorectal cancer. J Clin Oncol (2006) 2.77
Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan. J Clin Oncol (2009) 2.40
Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J Natl Cancer Inst (2002) 2.38
Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung. J Thorac Oncol (2012) 2.17
Gender medicine: a task for the third millennium. Clin Chem Lab Med (2013) 1.78
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS (2008) 1.66
Intake of selected micronutrients and the risk of surgically treated benign prostatic hyperplasia: a case-control study from Italy. Eur Urol (2005) 1.51
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial. Support Care Cancer (2010) 1.47
Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiol Biomarkers Prev (2006) 1.47
Carboxylesterase isoform 2 mRNA expression in peripheral blood mononuclear cells is a predictive marker of the irinotecan to SN38 activation step in colorectal cancer patients. Clin Cancer Res (2005) 1.47
Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer (2007) 1.40
Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience. Blood (2002) 1.35
Epidemiology of viral hepatitis infections in an area of southern Italy with high incidence rates of liver cancer. Eur J Cancer (2008) 1.33
Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer. J Clin Oncol (2009) 1.28
Solid pseudopapillary tumour of the pancreas. Lancet Oncol (2003) 1.24
Food groups and risk of non-Hodgkin lymphoma: a multicenter, case-control study in Italy. Int J Cancer (2006) 1.21
Incidence of AIDS-defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998. J Acquir Immune Defic Syndr (2003) 1.15
Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival. Clin Cancer Res (2009) 1.15
Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer. Oncotarget (2014) 1.14
Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer (2007) 1.12
5-Aza-2'-deoxycytidine (decitabine) treatment of hematopoietic malignancies: a multimechanism therapeutic approach? Blood (2003) 1.10
Family history of liver cancer and hepatocellular carcinoma. Hepatology (2012) 1.09
Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies. Ann Surg Oncol (2011) 1.08
Cisplatin and temozolomide combination in the treatment of leptomeningeal carcinomatosis from ethmoid sinus intestinal-type adenocarcinoma. J Neurooncol (2010) 1.08
Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients. Int J Cancer (2003) 1.08
Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis (2010) 1.07
Food groups and risk of hepatocellular carcinoma: A multicenter case-control study in Italy. Int J Cancer (2006) 1.06
Advances in targeting signal transduction pathways. Oncotarget (2012) 1.06
Hepatoid adenocarcinoma of the colon: what should we target? Pathol Oncol Res (2011) 1.05
C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation. Eur J Cancer (2009) 1.04
Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomas. Oncotarget (2011) 1.04
Flavonoids and the risk of oral and pharyngeal cancer: a case-control study from Italy. Cancer Epidemiol Biomarkers Prev (2007) 1.03
Nutrient-based dietary patterns and pancreatic cancer risk. Ann Epidemiol (2013) 1.01
Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis. Metabolism (2011) 1.01
Diabetes mellitus and cancer risk in a network of case-control studies. Nutr Cancer (2012) 1.00
Reproductive, menstrual, and other hormone-related factors and risk of renal cell cancer. Int J Cancer (2008) 1.00
Hypertension as a biomarker in patients with recurrent glioblastoma treated with antiangiogenic drugs: a single-center experience and a critical review of the literature. Anticancer Drugs (2013) 1.00
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. Hum Pathol (2013) 1.00
Smoking and body mass index and survival in pancreatic cancer patients. Pancreas (2014) 1.00
Neoplastic meningitis from solid tumors: new diagnostic and therapeutic approaches. Oncologist (2011) 0.99
Early HER2 dysregulation in gastric and oesophageal carcinogenesis. Histopathology (2012) 0.98
Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma. Blood (2002) 0.97
The impact of tobacco smoking and alcohol drinking on survival of patients with non-Hodgkin lymphoma. Int J Cancer (2008) 0.97
Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Am J Epidemiol (2013) 0.97
Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Eur J Cancer Prev (2009) 0.95
Epidemiology and pattern of care of breakthrough cancer pain in a longitudinal sample of cancer patients: results from the Cancer Pain Outcome Research Study Group. Clin J Pain (2011) 0.95
'Genetic profiling' and ovarian cancer therapy (review). Mol Med Rep (2011) 0.95
Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies. Leuk Lymphoma (2008) 0.95
PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage. Mol Med (2010) 0.94
Excess mortality for non–AIDS-defining cancers among people with AIDS. Clin Infect Dis (2010) 0.94
Pharmacokinetic optimisation of treatment with oral etoposide. Clin Pharmacokinet (2004) 0.94
Differential proteomic analysis of hepatocellular carcinoma. Int J Oncol (2010) 0.92
Lung cancer in persons with AIDS in Italy, 1985-1998. AIDS (2003) 0.92
Aspirin use and pancreatic cancer risk. Eur J Cancer Prev (2010) 0.92
Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan-based regimens. J Pharmacol Exp Ther (2013) 0.91
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study. Crit Rev Oncol Hematol (2008) 0.90
A liquid chromatography-tandem mass spectrometry method for the simultaneous determination of exemestane and its metabolite 17-dihydroexemestane in human plasma. J Mass Spectrom (2009) 0.89
Dietary total antioxidant capacity and colorectal cancer: a large case-control study in Italy. Int J Cancer (2013) 0.89
Fast liquid chromatography-tandem mass spectrometry method for routine assessment of irinotecan metabolic phenotype. Ther Drug Monit (2010) 0.89
The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples. Transl Oncol (2013) 0.88
Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa). World J Surg Oncol (2014) 0.88
First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease: clinical outcome and patterns of radiological response. Fam Cancer (2015) 0.87
Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study. BMC Cancer (2010) 0.86
Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review). Mol Med Rep (2010) 0.86
Trends in cancer incidence rates among HIV-infected patients. Clin Infect Dis (2005) 0.86
Risk factors for young-onset colorectal cancer. Cancer Causes Control (2012) 0.86
The role of laparoscopy in peritoneal surface malignancies selected for hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol (2012) 0.86
Extrahepatic disorders of HCV infection: a distinct entity of B-cell neoplasia? Int J Oncol (2010) 0.86
Lifetime occupational and recreational physical activity and risk of benign prostatic hyperplasia. Int J Cancer (2006) 0.86
Neoplastic pericardial disease in lung cancer: impact on outcomes of different treatment strategies. A multicenter study. Lung Cancer (2010) 0.86
Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab. Expert Opin Investig Drugs (2010) 0.85
Association between components of the insulin-like growth factor system and epithelial ovarian cancer risk. Oncology (2004) 0.85
Re: High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. J Natl Cancer Inst (2013) 0.85
Locoregional failure in early-stage breast cancer patients treated with radical mastectomy and adjuvant systemic therapy: which patients benefit from postmastectomy irradiation? Int J Radiat Oncol Biol Phys (2012) 0.84
Critical choices for modeling breast cancer in transgenic mouse models. J Cell Physiol (2012) 0.84
A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy. Clin Exp Med (2012) 0.84
Androgen receptor serine 81 mediates Pin1 interaction and activity. Cell Cycle (2012) 0.84
Advanced gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted therapies. Crit Rev Oncol Hematol (2011) 0.84
Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets. J Cell Physiol (2012) 0.84
Expert conference on cancer pain assessment and classification--the need for international consensus: working proposals on international standards. BMJ Support Palliat Care (2011) 0.83
Smoking and non-Hodgkin lymphoma: case-control study in Italy. Int J Cancer (2005) 0.83
Rapid and sensitive analysis of vincristine in human plasma using on-line extraction combined with liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom (2008) 0.83
Survival after cancer in Italian persons with AIDS, 1986-2005: a population-based estimation. J Acquir Immune Defic Syndr (2014) 0.83